Using cell and animal model experiments, we confirmed that CHIP could inhibit CRC cells proliferation, migration and invasion in vivo or vitro. Moreover, CHIP was an independent positive prognostic factor for CRC patients by univariate and multivariate Cox proportional hazards regression analysis. The gene discussed is STUB1; the disease is colorectal carcinoma.